Needle Biopsy Market Size, Share, Regional Trends, Industry Leading Players, and Forecast Period of 2022-2030
The Needle
Biopsy Market is expected to reach USD 24,421.3 Million
by 2030 at 12.5% CAGR during the forecast period 2022-2030. The needle biopsy
market is chiefly driven by product development and the fall in prices of raw
materials and components. The increasing cases of cancers and growing usage of
biopsy needles is driving the market. Companies should focus on improving the
distribution efficiency so as to reduce the pressures on prices due to huge
market fragmentation. Distributional agreements between large players and
advanced products such as multilayer needles will be extremely beneficial. The
emergence of needle biopsy is estimated to pose the greatest threat to the
biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for
detecting cancer as it used liquids such as blood, urine, saliva etc. to detect
malignancy. Increasing automation will enhance the capabilities of needle
biopsy and it may substitute the needle biopsy procedures. Real time
progression of cancers is also possible in needle biopsy which raises the level
of threat it possess to needle biopsy. The falling cost of products due to
greater market fragmentation and the emergence of Chinese companies is expected
to put additional pressures on prices.
In our estimates vacuum assisted needle biopsy will be the
fastest growing segment. The increasing screening rates for cancers through the
world will stimulate the market. Among the various cancers, breast cancer is
expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns
is another lucrative strategy that is being pursued by many players. Core
needle biopsy has a higher efficiency and detectability rate than fine needle
aspiration biopsy. There is increasing bias to use core needle biopsy in
combination with needle aspiration biopsy to achieve highest sensitivity and
detectability. Thus, the two tests are complementary, and the effectiveness
rate is highest with both tests are done together.
The growing stringent regulation and standards for medical
devices, and the increasing uncertainty about reimbursement in the US are
threatening the growth of the market.
Major Key
Players:
Some of the key Needle
Biopsy Market players are Boston Scientific Corporation, Cook
Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc.,
Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company,
Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others
Segment Analysis
The global needle biopsy market is segmented on the basis of type and
applications. Based on type, the market has been segmented as fine-needle
aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided
biopsy. Based on the utility, the market has been segmented as disposable and
reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.
Challenges and Future Prospects
Operator Skill and Training: Performing needle biopsy procedures requires
a high level of skill and expertise. Ensuring that healthcare professionals
receive adequate training is essential for maintaining the safety and efficacy
of these procedures.
Sample Adequacy: In some cases, needle biopsy samples may not
provide enough tissue for a conclusive diagnosis. Researchers are working on
innovative solutions to overcome this challenge and improve the diagnostic
yield.
Cost Implications: While needle biopsy procedures are generally
more cost-effective than traditional surgeries, the initial investment in
imaging equipment and specialized biopsy tools can be significant for
healthcare facilities.
Integration of Artificial Intelligence
(AI): The integration of AI and machine learning
algorithms holds the potential to revolutionize the needle biopsy process. AI
can assist in real-time image analysis, improving the accuracy of needle
placement and enhancing diagnostic outcomes.
Personalized Medicine and Biomarker
Discovery: Needle biopsy samples
offer a valuable resource for biomarker discovery and personalized medicine
initiatives. As our understanding of disease genetics and molecular profiles
grows, needle biopsy could play a central role in tailoring treatments to
individual patients.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment